Table 2.
Bacteria isolated from bloodstream infections in hematology patients
| n (%) | Fatal isolate (n) | |
|---|---|---|
| Extended-spectrum beta-lactamases (−) Escherichia coli | 14 (21) | 2 |
| Extended-spectrum beta-lactamases (−) Klebsiella pneumoniae | 8 (12) | |
| Vancomycin-sensitive Enterococcus faecalis | 6 (9) | 3 |
| Carbapenem-sensitive Pseudomonas aeruginosa | 6 (9) | |
| Extended-spectrum beta-lactamases (+) K. pneumoniae | 5 (8) | |
| Carbapenem-resistant Acinetobacter baumannii | 4 (6) | 2 |
| Methicillin-resistant Staphylococcus aureus | 4 (6) | 2 |
| Extended-spectrum beta-lactamases (+) E. coli | 3 (5) | |
| Methicillin-sensitive S. aureus | 2 (3) | |
| Vancomycin-resistant Enterococcus faecium | 2 (3) | 1 |
| Vancomycin-sensitive E. faecium | 2 (3) | 1 |
| Ochrobactrum anthropi | 1 (1.5) | |
| Methicillin-resistant coagulase-negative staphylococci | 1 (1.5) | |
| Extended-spectrum beta-lactamases (−) Klebsiella oxytoca | 1 (1.5) | |
| Stenotrophomonas maltophilia | 1 (1.5) | |
| Carbapenem-resistant P. aeruginosa | 1 (1.5) | 1 |
| Carbapenem-resistant Serratia marcescens | 1 (1.5) | |
| S. marcescens | 1 (1.5) | |
| Serratia ficaria | 1 (1.5) | |
| Citrobacter koseri | 1 (1.5) | |
| Enterobacter cloacae | 1 (1.5) | |
| Total | 66 (100) |